Cargando…
Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody
The Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic betacoronavirus that was first detected in humans in 2012 as a cause of severe acute respiratory disease. As of July 28, 2017, there have been 2,040 confirmed cases with 712 reported deaths. While many infections have been fat...
Autores principales: | Houser, Katherine V., Broadbent, Andrew J., Gretebeck, Lisa, Vogel, Leatrice, Lamirande, Elaine W., Sutton, Troy, Bock, Kevin W., Minai, Mahnaz, Orandle, Marlene, Moore, Ian N., Subbarao, Kanta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574614/ https://www.ncbi.nlm.nih.gov/pubmed/28817732 http://dx.doi.org/10.1371/journal.ppat.1006565 |
Ejemplares similares
-
Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)–Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection
por: Houser, Katherine V., et al.
Publicado: (2016) -
Animal models for SARS and MERS coronaviruses
por: Gretebeck, Lisa M, et al.
Publicado: (2015) -
The soft palate is an important site of adaptation for transmissible influenza viruses
por: Lakdawala, Seema S., et al.
Publicado: (2015) -
Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus
por: Sutton, Troy C., et al.
Publicado: (2015) -
Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine
por: Kapadia, Sagar U., et al.
Publicado: (2005)